Janssen partners with Koa Health on digital depression treatments
The global pharma firm will work with the digital mental health solutions specialist on solutions for treatment-resistant depressive order patients.
The global pharma firm will work with the digital mental health solutions specialist on solutions for treatment-resistant depressive order patients.
A recent survey conducted by Oracle reveals trial professionals’ thoughts, feelings and behavior around decentralized research in the face of the pandemic.
The division of the National Institutes of Health has begun enrolling hospitalized patients in a trial investigating various potential COVID-19 treatments.